XML 26 R9.htm IDEA: XBRL DOCUMENT v3.8.0.1
Cash, Cash Equivalents and Marketable Securities
9 Months Ended
Sep. 30, 2017
Cash Cash Equivalents And Short Term Investments [Abstract]  
Cash, Cash Equivalents and Marketable Securities

3. Cash, cash equivalents and marketable securities

Cash, cash equivalents and marketable securities consist of the following (in thousands):

 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Estimated Fair Value

 

September 30, 2017

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

$

2,972

 

 

$

-

 

 

$

-

 

 

$

2,972

 

Money market funds

 

14,124

 

 

 

-

 

 

 

-

 

 

 

14,124

 

Corporate debt securities

 

3,000

 

 

 

-

 

 

 

-

 

 

 

3,000

 

Total cash and cash equivalents

 

20,096

 

 

 

-

 

 

 

-

 

 

 

20,096

 

Marketable securities available-for-sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasuries

 

33,664

 

 

 

-

 

 

 

(15

)

 

 

33,649

 

U.S. government agency securities

 

95,748

 

 

 

-

 

 

 

(17

)

 

 

95,731

 

Corporate debt securities

 

42,200

 

 

 

4

 

 

 

-

 

 

 

42,204

 

Total marketable securities available-for-sale

 

171,612

 

 

 

4

 

 

 

(32

)

 

 

171,584

 

Total cash, cash equivalents and marketable securities

$

191,708

 

 

$

4

 

 

$

(32

)

 

$

191,680

 

December 31, 2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

$

3,557

 

 

$

-

 

 

$

-

 

 

$

3,557

 

Money market funds

 

18,981

 

 

 

-

 

 

 

-

 

 

 

18,981

 

U.S. government agency securities

 

1,751

 

 

 

-

 

 

 

-

 

 

 

1,751

 

Total cash and cash equivalents

 

24,289

 

 

 

-

 

 

 

-

 

 

 

24,289

 

Marketable securities available-for-sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasuries

 

3,499

 

 

 

-

 

 

 

-

 

 

 

3,499

 

U.S. government agency securities

 

28,685

 

 

 

3

 

 

 

(2

)

 

 

28,686

 

Corporate debt securities

 

24,938

 

 

 

5

 

 

 

(2

)

 

 

24,941

 

Total marketable securities available-for-sale

 

57,122

 

 

 

8

 

 

 

(4

)

 

 

57,126

 

Total cash, cash equivalents and marketable securities

$

81,411

 

 

$

8

 

 

$

(4

)

 

$

81,415

 

 

The maturities of our marketable securities available-for-sale are as follows (in thousands):

 

 

 

September 30, 2017

 

 

 

Amortized Cost

 

 

Estimated Fair Value

 

Mature in one year or less

 

$

171,612

 

 

$

171,584

 

Mature after one year through two years

 

 

-

 

 

 

-

 

 

 

$

171,612

 

 

$

171,584

 

 

There were no realized gains or losses from the sale of marketable securities during the nine months ended September 30, 2017 and 2016.

We have classified our entire investment portfolio as available-for-sale and available for use in current operations and accordingly have classified all investments as short-term. Available-for-sale securities are carried at fair value based on inputs that are observable, either directly or indirectly, such as quoted market prices for similar securities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the securities, with unrealized gains and losses included in accumulated other comprehensive loss in stockholders’ equity. Realized gains and losses and declines in value, if any, judged to be other than temporary on available-for-sale securities are included in interest income or expense. The cost of securities sold is based on the specific identification method. Management assesses whether declines in the fair value of investment securities are other than temporary. In determining whether a decline is other than temporary, management considers the following factors:

 

Whether the investment has been in a continuous realized loss position for over 12 months;

 

the duration to maturity of our investments;

 

our intention and ability to hold the investment to maturity and if it is not more likely than not that we will be required to sell the investment before recovery of the amortized cost bases;

 

the credit rating, financial condition and near-term prospects of the issuer; and

 

the type of investments made.

To date, there have been no declines in fair value that have been identified as other than temporary.